TY  - RPRT
TI  - Targeting the menopause transition with metformin improves breast cancer outcomes, but discontinuation has deleterious effects on metabolic health: Findings from a preclinical model of postmenopausal breast cancer.
AU  - Corleto, K. A.
AU  - Schedin, P.
AU  - Kotta, A. S.
AU  - Strandmo, J. L.
AU  - Foster, S. M.
AU  - Lammoglia, N.
AU  - Karmakar, M.
AU  - Carroll, R. J.
AU  - MacLean, P. S.
AU  - Giles, E. D.
PY  - 2024
DO  - 10.1101/2024.11.25.625083
UR  - https://www.biorxiv.org/content/10.1101/2024.11.25.625083v1
ID  - 10.1101/2024.11.25.625083
ER  -